Corporate News     13-Sep-21
Advanced Enzyme updates on clinical trials for its health supplements
To treat post-Covid fatigue complications
Advanced Enzyme Technologies announced that its systemic enzyme and probiotic supplements¡ªImmunoSEB and ProbioSEB CSC3 have passed the promising stages of randomized controlled clinical trials in terms of efficacy to resolve post©\COVID fatigue symptoms.

It¡¯s a fact that muscle fatigue and cognitive disturbances persist in patients after recovery from acute COVID©\19 disease. However, there are no specific treatments available globally to treat post©\COVID fatigue complications.

With an aim to evaluate the efficacy and safety of the health supplements ImmunoSEB (systemic enzyme complex) and ProbioSEB CSC3 (probiotic complex) in patients suffering from COVID©\19 induced fatigue, a randomized, multi©\centric, double blind and placebo©\controlled trial was conducted in 200 patients suffering from post©\COVID fatigue symptoms.

Previous News
  Advanced Enzyme Technologies consolidated net profit rises 41.88% in the December 2023 quarter
 ( Results - Announcements 10-Feb-24   13:40 )
  Advanced Enzyme Technologies consolidated net profit rises 31.48% in the March 2023 quarter
 ( Results - Announcements 13-May-23   14:24 )
  Volumes soar at Can Fin Homes Ltd counter
 ( Hot Pursuit - 20-Sep-22   14:30 )
  Advanced Enzyme Technologies consolidated net profit declines 4.38% in the December 2018 quarter
 ( Results - Announcements 09-Feb-19   16:38 )
  Board of Advanced Enzyme Techs. recommends Final Dividend
 ( Corporate News - 13-May-23   17:01 )
  Volumes spurt at Advanced Enzyme Technologies Ltd counter
 ( Hot Pursuit - 17-Jun-21   14:30 )
  Advanced Enzyme Technologies fixes record date for final dividend
 ( Market Beat - Reports 25-Jun-24   18:39 )
  Advanced Enzyme Technologies consolidated net profit rises 28.21% in the December 2020 quarter
 ( Results - Announcements 12-Feb-21   13:32 )
  Advanced Enzyme Technologies consolidated net profit rises 18.25% in the March 2019 quarter
 ( Results - Announcements 24-May-19   17:01 )
  Advanced Enzyme Tech gains after strong Q4 performance
 ( Hot Pursuit - 15-May-23   10:08 )
  Advanced Enzyme Technologies allots 4500 equity shares under ESOS
 ( Corporate News - 12-Feb-21   12:26 )
Other Stories
  Board of Delhivery approves alteration in capital clause of MoA
  05-Jul-24   19:32
  J B Chemicals & Pharmaceuticals appoints director
  05-Jul-24   19:30
  Infosys announces resignation of senior management personnel
  05-Jul-24   19:22
  JLR Q1 FY25 retail sales up 9% on YoY basis
  05-Jul-24   19:08
  Bajaj Auto launches world's first CNG motorcycle 'Freedom'
  05-Jul-24   18:59
  Agenda for board meeting of Power Grid Corporation of India
  05-Jul-24   18:46
  Board of Bank of Baroda approves raising additional capital up to Rs 7,500 cr in FY25
  05-Jul-24   18:06
  Vipul to hold board meeting
  05-Jul-24   17:15
  Markobenz Ventures to convene board meeting
  05-Jul-24   17:15
  Dhanashree Electronics to declare Quarterly Result
  05-Jul-24   17:15
Back Top